Deciphera Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DCPH and buy or sell other stocks, ETFs, and their options commission-free!About DCPH
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors.
CEORyota Udagawa
CEORyota Udagawa
Employees—
Employees—
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2003
Founded2003
Employees—
Employees—
DCPH Key Statistics
Market cap2.21B
Market cap2.21B
Price-Earnings ratio-11.58
Price-Earnings ratio-11.58
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$25.61
52 Week high$25.61
52 Week low$9.90
52 Week low$9.90
Stock Snapshot
As of today, Deciphera Pharmaceuticals(DCPH) shares are valued at $25.59. The company's market cap stands at 2.21B, with a P/E ratio of -11.58.
During the trading day, Deciphera Pharmaceuticals(DCPH) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Deciphera Pharmaceuticals(DCPH) stock has reached 0.
The stock's 52-week range extends from a low of $9.90 to a high of $25.61.
The stock's 52-week range extends from a low of $9.90 to a high of $25.61.
People also own
Based on the portfolios of people who own DCPH. This list is generated using Robinhood data, and it’s not a recommendation.